Bavarian Nordic A/S Logo

Bavarian Nordic A/S (0DPB)

LSE

Currency in DKK
212.10
0.00 (0.00%)

Real-time Data

07:00 AM

Day's Range

211.00
214.60

52 wk Range

171.55
242.30

Overview - 0DPB - Bavarian Nordic A/S

Key Statistics

Valuation

Enterprise Value

8.63B

P/E (Trailing)

‪15.05‬

PEG Ratio

‪-0.16‬

Price / Sales (TTM)

‪3.59‬

Price / Book

‪1.65‬

EV / EBITDA

‪5.18‬

Profitability

Gross Margin

‪44.82%‬

Profit Margin

‪19.45%‬

Operating Margin

‪22.95%‬

Return on Assets

‪5.87%‬

Return on Equity

‪12.99%‬

Ownership

Shares Outstanding

77.14M

Float

75.71M

Held by Insiders

‪0.09%‬

Held by Institutions

‪30.60%‬

Price stats

Beta

‪1.29‬

50-Day Avg

‪182.14‬

200-Day Avg

‪206.23‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 0DPB - Bavarian Nordic A/S

Peers - 0DPB - Bavarian Nordic A/S

Peer Comparison

Compared with companies in Biotechnology listed on LSE.

Profile Summary - 0DPB - Bavarian Nordic A/S

About

Bavarian Nordic A/S is a Danish biotechnology company specializing in the research, development, manufacturing, and commercialization of innovative vaccines based on viral vector technologies. Headquartered in Hellerup, Denmark, with manufacturing facilities in Denmark and Switzerland, and R&D sites in Germany plus…

SectorHealthcare
IndustryBiotechnology
Employees1.73K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.